查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1954608

全球軍團菌檢測市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析以及未來預測（2026-2034 年）

Legionella Testing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 125 Pages | 商品交期: 請詢問到貨日

價格

軍團菌檢測市場成長驅動因素

2025 年全球軍團菌檢測市場規模為 3.793 億美元，預計將從 2026 年的 4.151 億美元增長至 2034 年的 8.838 億美元，預測期內（2026-2034 年）複合年增長率 (CAGR) 為 9.90%。退伍軍人病發病率的上升、人們對水傳播感染的認識不斷提高以及快速診斷技術的廣泛應用，推動了該市場的持續穩定成長。 2025 年，北美市場將以 39.50% 的市佔率領先，這得益於其完善的監管架構和先進的醫療保健基礎設施。

市場概覽

軍團菌是一種廣泛存在於淡水環境中的細菌，例如池塘、湖泊、淋浴間、熱水浴池、冷卻水塔和儲水系統。它們特別在 20°C 至 40°C 的溫度條件下繁殖，並可引起退伍軍人病和龐蒂亞克熱等呼吸道疾病。

已開發國家，特別是針對日益增長的公共衛生問題，已出台了嚴格的水質定期檢測法規。自 1997 年美國退伍軍人病病例增加以來，當局已強制要求對供水系統進行檢查。根據世界衛生組織（WHO）2022年的數據，美國、歐洲和澳洲每年每百萬人中約有10至15例感染病例。

新冠疫情對市場的影響

在新冠疫情期間，由於生產中斷、供應鏈挑戰以及醫療系統優先進行新冠病毒檢測，市場成長暫時放緩。此外，新冠病毒感染和退伍軍人病的臨床症狀相似，導致軍團菌檢測率下降。

然而，疫情後時期創造了新的成長機會。建築物長期關閉導致水系統停滯，增加了軍團菌滋生的風險。 2021年，美國疾病管制與預防中心（CDC）建議在設施重新開放前，對熱水浴池和儲水箱等水系統進行檢測。這導致2025年後對軍團菌檢測解決方案的需求顯著增長。

市場趨勢

快速檢測方法的廣泛應用

市場正從傳統的培養方法轉向先進的診斷技術，例如尿液抗原檢測 (UAT) 和聚合酶鍊式反應 (PCR)。

  • PCR 檢測具有高靈敏度 (95–99%)，可快速檢測多種軍團菌血清型。 即時 PCR 試劑盒越來越多地應用於醫院和現場檢測。 快速分子診斷正在提高準確性，並實現疾病的早期發現。

這些技術進步是推動市場成長的主要因素，預計市場規模將從2026年的4.151億美元成長到2034年的8.838億美元。

市場成長驅動因素

1.退伍軍人症發生率上升

全球病例數的增加推動了對檢測試劑盒的需求。根據美國勞工部報告，美國每年約有6,000例軍團病病例。醫院感染也是一個令人擔憂的問題。台灣的一項研究發現，在受調查的醫院中，63%的醫院的供水系統中檢測到了嗜肺軍團菌。

2. 嚴格的監理政策

世界各國正在實施水管理指南。世界衛生組織提供了七份關於風險管理的關鍵指南文件。在歐洲，歐洲軍團病控制工作小組（EWGLI）支援監測計畫。這些強化的監管正在推動市場成長。

市場限制因子

儘管成長前景強勁，但發展中國家的認知度較低限制了市場擴張。在印度等國家，由於退伍軍人症的症狀與肺炎和結核病相似，因此常常難以確診。此外，新興市場對即時PCR等先進診斷技術的依賴性低，以及相關基礎設施不足，也阻礙了這些技術的普及。

市場區隔分析

依類型

市場依類型細分為培養基、尿抗原檢測、PCR、血清學檢測和直接免疫螢光檢測。

  • 由於尿抗原檢測（UAT）價格實惠且當天即可出結果，預計到2026年，UAT將佔最大的市場佔有率，達到42.12%。然而，UAT主要檢測的是LP1。
  • 由於PCR檢測具有更高的靈敏度和準確性，因此預計其市場成長速度最快。

依最終使用者劃分

細分市場包括醫院和診所、臨床實驗室、環境檢測機構。

  • 臨床實驗室佔市場主導地位，預計由於疾病流行率上升和先進診斷技術的普及，將繼續保持領先地位。
  • 由於現場檢測解決方案和監管要求，環境檢測正在迅速發展。

區域洞察

北美

預計2025年，北美市場規模將達到1.4965億美元。強而有力的監管、較高的健康意識以及龐大的老年人口是推動市場需求的主要因素。

歐洲

由於疫情蔓延和PCR檢測的引入，歐洲佔了第二大市場佔有率。

亞太地區

在醫療基礎設施改善和公眾意識提高的推動下，亞太地區預計到2034年將以最高的複合年增長率增長。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：主要發現

  • 全球市場主要趨勢
  • 新產品發布與核准：依主要公司劃分
  • 關鍵趨勢：併購、業務合作等
  • 最新技術進展
  • 監理環境洞察
  • 波特五力分析
  • 關稅對市場的影響

第四章 主要考慮因素

  • 軍團菌感染爆發：依主要國家劃分
  • 關鍵產業趨勢：併購、業務合作
  • 軍團菌檢測試劑盒的技術進步
  • 主要國家的監管狀況
  • 新冠疫情對市場的影響

第五章 全球軍團菌檢測市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依國家劃分類型
    • 培養基
    • 尿抗原檢測 (UAT)
    • 聚合酶鍊式反應 (PCR)
    • 血清學
    • 直接免疫螢光 (DFA)
  • 市場分析、洞察與預測：依最終用戶劃分
    • 醫院和診所
    • 臨床實驗室
    • 其他
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美軍團菌檢測市場分析：洞察與預測 (2021-2034)

  • 依國家劃分
    • 美國州/省
    • 加拿大

第七章 歐洲軍團菌檢測市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家

第八章 亞太地區軍團菌檢測市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 中國
    • 日本
    • 韓國
    • 印度
    • 澳大利亞
    • 台灣
    • 印尼
    • 其他亞太地區

章節9 拉丁美洲軍團菌檢測市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第 10 章 中東與非洲軍團菌檢測市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會 (GCC) 國家
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市場佔有率分析(2025年)
  • 企業簡介
    • Quidel Corporation
    • Abbott
    • Merck KGaA
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • BD
    • bioMerieux
    • IDEXX Corporation
    • Eurofins Scientific
Product Code: FBI102803

Growth Factors of Legionella testing Market

The global Legionella testing market was valued at USD 379.3 million in 2025 and is projected to grow from USD 415.1 million in 2026 to USD 883.8 million by 2034, exhibiting a CAGR of 9.90% during the forecast period (2026-2034). The market is witnessing steady expansion due to the rising prevalence of Legionnaires' disease, increasing awareness regarding waterborne infections, and the growing adoption of rapid diagnostic technologies. In 2025, North America dominated the market with a 39.50% share, supported by strong regulatory frameworks and advanced healthcare infrastructure.

Market Overview

Legionella is a bacterial species commonly found in freshwater environments such as ponds, lakes, showers, hot tubs, cooling towers, and water storage systems. Under favorable conditions, particularly temperatures between 20°C and 40°C, the bacteria multiply and can cause respiratory illnesses such as Legionnaires' disease and Pontiac fever.

Growing public health concerns, especially in developed countries, have led to stringent regulations for regular water testing. Following the increased prevalence of Legionella infections in the U.S. since 1997, authorities implemented mandatory testing of water systems. According to WHO data (2022), approximately 10-15 cases per million population are detected annually across the U.S., Europe, and Australia.

Impact of COVID-19 on the Market

During the COVID-19 pandemic, the market experienced temporary slow growth due to manufacturing disruptions, supply chain challenges, and healthcare systems prioritizing coronavirus testing. Additionally, similarities in clinical symptoms between COVID-19 and Legionnaires' disease resulted in reduced Legionella testing rates.

However, the post-pandemic period has created renewed growth opportunities. Prolonged building closures led to stagnant water systems, increasing the risk of Legionella proliferation. In 2021, the CDC recommended testing water systems such as hot tubs and storage tanks before reopening facilities. This has significantly boosted demand for Legionella testing solutions in 2025 and beyond.

Market Trends

Growing Adoption of Rapid Testing Methods

The market is witnessing a shift from traditional culture methods to advanced diagnostic technologies such as Urine Antigen Testing (UAT) and Polymerase Chain Reaction (PCR).

  • PCR testing offers high sensitivity (95-99%) and detects multiple Legionella serotypes with faster turnaround times.
  • Real-time PCR kits are increasingly adopted for hospital-based and onsite testing.
  • Rapid molecular diagnostics are improving accuracy and enabling early disease detection.

These technological advancements are key contributors to the projected growth from USD 415.1 million in 2026 to USD 883.8 million by 2034.

Market Growth Drivers

1. Rising Prevalence of Legionnaires' Disease

Increasing global cases are driving demand for testing kits. The U.S. Department of Labor reports approximately 6,000 Legionella cases annually in the U.S. Hospital-acquired infections are also a concern. A study in Taiwan revealed that 63% of surveyed hospitals tested positive for Legionella pneumophila in their water systems.

2. Stringent Regulatory Policies

Governments worldwide are enforcing water management guidelines. The WHO provides seven principal guidance documents for risk management. In Europe, the European Working Group for Legionella Infections (EWGLI) supports surveillance programs. Such regulatory emphasis is strengthening market growth.

Market Restraints

Despite strong growth prospects, limited awareness in underdeveloped countries restrains market expansion. In countries like India, Legionella infections are often underdiagnosed due to overlapping symptoms with pneumonia and tuberculosis. High costs of advanced diagnostics such as real-time PCR and lack of infrastructure also hinder adoption in emerging markets.

Segmentation Analysis

By Type

The market is segmented into culture media, urine antigen testing, PCR, serology tests, and direct fluorescent antibody methods.

  • Urine Antigen Testing (UAT) held the largest market share of 42.12% in 2026, due to affordability and same-day results. However, it primarily detects LP1 species.
  • PCR testing is projected to witness the fastest growth due to superior sensitivity and accuracy.

By End-User

Segments include hospitals & clinics, clinical laboratories, and environmental testing sites.

  • Clinical laboratories dominated the market and are expected to maintain leadership due to rising disease prevalence and advanced diagnostic penetration.
  • Environmental testing is expanding rapidly due to onsite testing solutions and regulatory mandates.

Regional Insights

North America

The market size in North America reached USD 149.65 million in 2025. Strong regulatory enforcement, high awareness, and a large geriatric population drive demand.

Europe

Europe holds the second-largest share due to increasing outbreaks and adoption of PCR testing.

Asia Pacific

Asia Pacific is projected to grow at the highest CAGR through 2034, supported by improving healthcare infrastructure and rising awareness.

Competitive Landscape

The market is consolidated, with key players including Abbott, Thermo Fisher Scientific, Bio-Rad Laboratories, Merck KGaA, IDEXX Corporation, BD, bioMerieux, and Eurofins Scientific. Companies are focusing on mergers, acquisitions, and product launches to expand their portfolios.

Conclusion

The global Legionella testing market is set for strong growth, rising from USD 379.3 million in 2025 to USD 883.8 million by 2034, driven by increasing disease prevalence, stringent water safety regulations, and rapid adoption of advanced diagnostic technologies such as PCR and UAT. While limited awareness in emerging economies poses challenges, expanding regulatory frameworks and technological innovations are expected to sustain long-term market expansion. As governments and healthcare institutions prioritize water safety and infection prevention, Legionella testing will remain a critical component of global public health strategies.

Segmentation

By Type

  • Culture Media
  • Urine Antigen Testing (UAT)
  • Polymerase Chain Reaction (PCR)
  • Serology
  • Direct Fluorescent Antibody (DFA) Test

By End-User

  • Hospitals & Clinics
  • Clinical Laboratories
  • Others

By Geography

  • North America (By Type, End-User, and Country)
    • U.S.
    • Canada
  • Europe (By Type, End-User, and Country/Sub region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific (By Type, End-User, and Country/Sub region)
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Taiwan
    • Indonesia
    • Rest of Asia Pacific
  • Latin America (By Type, End-User, and Country/Sub region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, End-User, and Country/Sub region)
    • South Africa
    • GCC
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Legionella Infection, By Key Countries
  • 4.2. Key Industry Developments - Merges, Acquisitions and Partnerships
  • 4.3. Technological Advancements in Legionella Testing Kits
  • 4.4. Regulatory Scenario, By Key Countries
  • 4.5. Impact of COVID-19 on the Market

5. Global Legionella Testing Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Culture Media
    • 5.1.2. Urine Antigen Testing (UAT)
    • 5.1.3. Polymerase Chain Reaction (PCR)
    • 5.1.4. Serology
    • 5.1.5. Direct Fluorescent Antibody Test (DFA)
  • 5.2. Market Analysis, Insights and Forecast - By End User
    • 5.2.1. Hospitals & Clinics
    • 5.2.2. Clinical Laboratories
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East & Africa

6. North America Legionella Testing Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Culture Media
    • 6.1.2. Urine Antigen Testing (UAT)
    • 6.1.3. Polymerase Chain Reaction (PCR)
    • 6.1.4. Serology
    • 6.1.5. Direct Fluorescent Antibody Test (DFA)
  • 6.2. Market Analysis, Insights and Forecast - By End User
    • 6.2.1. Hospitals & Clinics
    • 6.2.2. Clinical Laboratories
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S.
    • 6.3.2. Canada

7. Europe Legionella Testing Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Culture Media
    • 7.1.2. Urine Antigen Testing (UAT)
    • 7.1.3. Polymerase Chain Reaction (PCR)
    • 7.1.4. Serology
    • 7.1.5. Direct Fluorescent Antibody Test (DFA)
  • 7.2. Market Analysis, Insights and Forecast - By End User
    • 7.2.1. Hospitals & Clinics
    • 7.2.2. Clinical Laboratories
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.3.1. U.K
    • 7.3.2. Germany
    • 7.3.3. France
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Rest of Europe

8. Asia Pacific Legionella Testing Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Culture Media
    • 8.1.2. Urine Antigen Testing (UAT)
    • 8.1.3. Polymerase Chain Reaction (PCR)
    • 8.1.4. Serology
    • 8.1.5. Direct Fluorescent Antibody Test (DFA)
  • 8.2. Market Analysis, Insights and Forecast - By End User
    • 8.2.1. Hospitals & Clinics
    • 8.2.2. Clinical Laboratories
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
    • 8.3.4. India
    • 8.3.5. Australia
    • 8.3.6. Taiwan
    • 8.3.7. Indonesia
    • 8.3.8. Rest of Asia Pacific

9. Latin America Legionella Testing Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Culture Media
    • 9.1.2. Urine Antigen Testing (UAT)
    • 9.1.3. Polymerase Chain Reaction (PCR)
    • 9.1.4. Serology
    • 9.1.5. Direct Fluorescent Antibody Test (DFA)
  • 9.2. Market Analysis, Insights and Forecast - By End User
    • 9.2.1. Hospitals & Clinics
    • 9.2.2. Clinical Laboratories
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.3.1. Brazil
    • 9.3.2. Mexico
    • 9.3.3. Rest of Latin America

10. Middle East & Africa Legionella Testing Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Culture Media
    • 10.1.2. Urine Antigen Testing (UAT)
    • 10.1.3. Polymerase Chain Reaction (PCR)
    • 10.1.4. Serology
    • 10.1.5. Direct Fluorescent Antibody Test (DFA)
  • 10.2. Market Analysis, Insights and Forecast - By End User
    • 10.2.1. Hospitals & Clinics
    • 10.2.2. Clinical Laboratories
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.3.1. GCC
    • 10.3.2. South Africa
    • 10.3.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Quidel Corporation
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. financials (Based on Availability)
    • 11.2.2. Abbott
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. financials (Based on Availability)
    • 11.2.3. Merck KGaA
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. financials (Based on Availability)
    • 11.2.4. Bio-Rad Laboratories, Inc.
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. financials (Based on Availability)
    • 11.2.5. Thermo Fisher Scientific Inc.
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. financials (Based on Availability)
    • 11.2.6. BD
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. financials (Based on Availability)
    • 11.2.7. bioMerieux
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. financials (Based on Availability)
    • 11.2.8. IDEXX Corporation
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. financials (Based on Availability)
    • 11.2.9. Eurofins Scientific
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. financials (Based on Availability)

List of Tables

  • Table 1: Global Legionella Testing Market Revenue (USD Million) Forecast, by Type, 2021-2034
  • Table 2: Global Legionella Testing Market Revenue (USD Million) Forecast, by End-user, 2021-2034
  • Table 3: Global Legionella Testing Market Revenue (USD Million) Forecast, by Region, 2021-2034
  • Table 4: North America Legionella Testing Market Revenue (USD Million) Forecast, by Type, 2021-2034
  • Table 5: North America Legionella Testing Market Revenue (USD Million) Forecast, by End-user, 2021-2034
  • Table 6: North America Legionella Testing Market Revenue (USD Million) Forecast, by Country, 2021-2034
  • Table 7: Europe Legionella Testing Market Revenue (USD Million) Forecast, by Type, 2021-2034
  • Table 8: Europe Legionella Testing Market Revenue (USD Million) Forecast, by End-user, 2021-2034
  • Table 9: Europe Legionella Testing Market Revenue (USD Million) Forecast, by Country/ Sub-region, 2021-2034
  • Table 10: Asia Pacific Legionella Testing Market Revenue (USD Million) Forecast, by Type, 2021-2034
  • Table 11: Asia Pacific Legionella Testing Market Revenue (USD Million) Forecast, by End-user, 2021-2034
  • Table 12: Asia Pacific Legionella Testing Market Revenue (USD Million) Forecast, by Country/ Sub-region, 2021-2034
  • Table 13: Latin America Legionella Testing Market Revenue (USD Million) Forecast, by Type, 2021-2034
  • Table 14: Latin America Legionella Testing Market Revenue (USD Million) Forecast, by End-user, 2021-2034
  • Table 15: Latin America Legionella Testing Market Revenue (USD Million) Forecast, by Country/ Sub-region, 2021-2034
  • Table 16: Middle East & Africa Legionella Testing Market Revenue (USD Million) Forecast, by Type, 2021-2034
  • Table 17: Middle East & Africa Legionella Testing Market Revenue (USD Million) Forecast, by End-user, 2021-2034
  • Table 18: Middle East & Africa Legionella Testing Market Revenue (USD Million) Forecast, by Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Legionella Testing Market Revenue Breakdown (USD Million, %) by Region, 2025 & 2034
  • Figure 2: Global Legionella Testing Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Legionella Testing Market Forecast (USD Million), by Culture Media, 2021-2034
  • Figure 4: Global Legionella Testing Market Forecast (USD Million), by Urine Antigen Testing (UAT), 2021-2034
  • Figure 5: Global Legionella Testing Market Forecast (USD Million), by Polymerase Chain Reaction (PCR), 2021-2034
  • Figure 6: Global Legionella Testing Market Forecast (USD Million), by Serology, 2021-2034
  • Figure 7: Global Legionella Testing Market Forecast (USD Million), by Direct Fluorescent Antibody Test (DFA), 2021-2034
  • Figure 8: Global Legionella Testing Market Value Share (%), by End-user, 2025 & 2034
  • Figure 09: Global Legionella Testing Market Value (USD Million), by Region, 2025 & 2034
  • Figure 10: North America Legionella Testing Market Value (USD Million), by Type, 2025 & 2034
  • Figure 11: North America Legionella Testing Market Value Share (%), by Type, 2025
  • Figure 12: North America Legionella Testing Market Value (USD Million), by End-user, 2025 & 2034
  • Figure 13: North America Legionella Testing Market Value Share (%), by End-user, 2025
  • Figure 14: North America Legionella Testing Market Value (USD Million), by Country, 2025 & 2034
  • Figure 15: North America Legionella Testing Market Value Share (%), by Country, 2025
  • Figure 16: Europe Legionella Testing Market Value (USD Million), by Type, 2025 & 2034
  • Figure 17: Europe Legionella Testing Market Value Share (%), by Type, 2025
  • Figure 18: Europe Legionella Testing Market Value (USD Million), by End-user, 2025 & 2034
  • Figure 19: Europe Legionella Testing Market Value Share (%), by End-user, 2025
  • Figure 20: Europe Legionella Testing Market Value (USD Million), by Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Legionella Testing Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Legionella Testing Market Value (USD Million), by Type, 2025 & 2034
  • Figure 23: Asia Pacific Legionella Testing Market Value Share (%), by Type, 2025
  • Figure 24: Asia Pacific Legionella Testing Market Value (USD Million), by End-user, 2025 & 2034
  • Figure 25: Asia Pacific Legionella Testing Market Value Share (%), by End-user, 2025
  • Figure 26: Asia Pacific Legionella Testing Market Value (USD Million), by Country/ Sub-region, 2025 & 2034
  • Figure 27: Asia Pacific Legionella Testing Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 28: Latin America Legionella Testing Market Value (USD Million), by Type, 2025 & 2034
  • Figure 29: Latin America Legionella Testing Market Value Share (%), by Type, 2025
  • Figure 30: Latin America Legionella Testing Market Value (USD Million), by End-user, 2025 & 2034
  • Figure 31: Latin America Legionella Testing Market Value Share (%), by End-user, 2025
  • Figure 32: Latin America Legionella Testing Market Value (USD Million), by Country/ Sub-region, 2025 & 2034
  • Figure 33: Latin America Legionella Testing Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 34: Middle East & Africa Legionella Testing Market Value (USD Million), by Type, 2025 & 2034
  • Figure 35: Middle East & Africa Legionella Testing Market Value Share (%), by Type, 2025
  • Figure 36: Middle East & Africa Legionella Testing Market Value (USD Million), by End-user, 2025 & 2034
  • Figure 37: Middle East & Africa Legionella Testing Market Value Share (%), by End-user, 2025
  • Figure 38: Middle East & Africa Legionella Testing Market Value (USD Million), by Country/ Sub-region, 2025 & 2034
  • Figure 39: Middle East & Africa Legionella Testing Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 40: Global Legionella Testing Market Share (%), By Company, 2025